176 related articles for article (PubMed ID: 30006785)
1. Ghrelin and acyl ghrelin levels are associated with inflammatory and nutritional markers and with cardiac and vascular dysfunction parameters in hemodialysis patients.
Rusu CC; Racasan S; Moldovan D; Potra A; Tirinescu D; Budurea C; Orasan R; Patiu IM; Bondor C; Vladutiu D; Delean D; Danu A; Kacso IM
Int Urol Nephrol; 2018 Oct; 50(10):1897-1906. PubMed ID: 30006785
[TBL] [Abstract][Full Text] [Related]
2. N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease.
Rusu CC; Anton F; Valea A; Bondor CI
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891884
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.
Ikeda M; Honda H; Takahashi K; Shishido K; Shibata T
PLoS One; 2016; 11(11):e0166804. PubMed ID: 27870908
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
6. The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients.
Bednarek-Skublewska A; Zaluska W; Ksiazek A
Clin Nephrol; 2010 Jan; 73(1):14-20. PubMed ID: 20040347
[TBL] [Abstract][Full Text] [Related]
7. Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.
Snaedal S; Qureshi AR; Carrero JJ; Heimbürger O; Stenvinkel P; Bárány P
Blood Purif; 2014; 37(2):138-45. PubMed ID: 24732340
[TBL] [Abstract][Full Text] [Related]
8. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
9. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
[TBL] [Abstract][Full Text] [Related]
10. Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patients.
Beberashvili I; Sinuani I; Azar A; Shapiro G; Feldman L; Doenyas-Barak K; Stav K; Efrati S
BMC Nephrol; 2017 Jan; 18(1):29. PubMed ID: 28100170
[TBL] [Abstract][Full Text] [Related]
11. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
[TBL] [Abstract][Full Text] [Related]
12. Is there association between acyl-ghrelin and inflammation in hemodialysis patients?
Barros Ade F; Moraes C; Pinto MB; Lobo JC; Mafra D
J Bras Nefrol; 2013; 35(2):120-6. PubMed ID: 23812569
[TBL] [Abstract][Full Text] [Related]
13. Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
Beberashvili I; Katkov A; Sinuani I; Azar A; Shapiro G; Feldman L; Gorelik O; Stav K; Efrati S
Am J Nephrol; 2018; 47(4):254-265. PubMed ID: 29694945
[TBL] [Abstract][Full Text] [Related]
14. The impact of dialysis type on biomarkers for cardiovascular diseases.
Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
[TBL] [Abstract][Full Text] [Related]
15. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
17. Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease.
Borges N; Moraes C; Barros AF; Carraro-Eduardo JC; Fouque D; Mafra D
J Ren Nutr; 2014 Mar; 24(2):100-4. PubMed ID: 24462497
[TBL] [Abstract][Full Text] [Related]
18. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
19. [Determining factors of cardiac biomarkers in hemodialysed diabetic and non-diabetic patients].
Mácsai E; Széll J; Ladányi E; Treszl A; Vásárhelyi B; Madácsy L
Orv Hetil; 2007 Mar; 148(11):483-8. PubMed ID: 17350919
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
